November 2, 2012

New recall issued for medicines in Maine

The pharmacy Ameridose says the move is precautionary, but the state asks that it give up its license.

By Eric Russell erussell@pressherald.com
Staff Writer

(Continued from page 1)

click image to enlarge

Ameridose Sterile Admixing Services in Westborough, Mass. Officials said Wednesday the pharmacy agreed to be shut down for state and federal inspection.

AP

Related headlines

Ameridose has 30 days to surrender its license in Maine. Pharmacy board Chairman Joe Bruno said he doesn't think there will be a huge impact if Ameridose no longer does business in Maine. "There are other companies out there," he said.

State Rep. Sharon Treat, D-Hallowell, attended Thursday's meeting of the pharmacy board and said she nearly missed action on Ameridose and New England Compounding Center because the board does not identify names or organizations during complaint hearings.

Each complaint is assigned a number, and board members discuss the facts of each complaint, but all identifying information is withheld.

Bruno said that's standard practice, and information about the companies is made public only after action is taken. After the meeting, Bruno confirmed the action that was taken regarding Ameridose and New England Compounding Center.

Treat, who serves on the Legislature's Insurance and Financial Affairs Committee, said what has happened in Massachusetts should prompt policymakers here to look at regulation of compounding pharmacies.

Maine does not have facilities that do high-volume compounding -- mixing of pharmaceuticals. Compounding is done here on a case-by-case basis, as outlined in state statute.

Treat said Maine should be sure that statute is being followed.

"What we've seen in Massachusetts suggests that there hasn't been a lot of accountability in this area," she said. "We should be asking if there is adequate enforcement of these rules."

Staff Writer Eric Russell can be contacted at 791-6344 or at:

erussell@mainetoday.com

Twitter: @PPHEricRussell

 

Were you interviewed for this story? If so, please fill out our accuracy form

Send question/comment to the editors




Further Discussion

Here at PressHerald.com we value our readers and are committed to growing our community by encouraging you to add to the discussion. To ensure conscientious dialogue we have implemented a strict no-bullying policy. To participate, you must follow our Terms of Use.

Questions about the article? Add them below and we’ll try to answer them or do a follow-up post as soon as we can. Technical problems? Email them to us with an exact description of the problem. Make sure to include:
  • Type of computer or mobile device your are using
  • Exact operating system and browser you are viewing the site on (TIP: You can easily determine your operating system here.)